TrivarX

TrivarX Equity

The The Equity of TrivarX (TRI.AX) as of Nov 17, 2026 is 15.97 M AUD. In the previous year, The Equity was 12.65 M AUD — a change of 26.21% (higher).

Equity

15.97 MAUD

YoY

26.21%

Last updated:

In 2026, TrivarX's equity was 15.97 M AUD, a 26.21% increase from the 12.65 M AUD equity in the previous year.

The TrivarX Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
8.60 M AUD
Jan 1, 2020
12.61 M AUD
Jan 1, 2021
16.42 M AUD
Jan 1, 2022
7.11 M AUD
Jan 1, 2023
6.30 M AUD
Jan 1, 2024
9.88 M AUD
Jan 1, 2025
12.65 M AUD
Jan 1, 2026
15.97 M AUD
The TrivarX Equity history
YEAREquityYoY
15.97 MAUD+26.21%
12.65 MAUD+28.02%
9.88 MAUD+56.96%
6.30 MAUD-11.39%
7.11 MAUD-56.71%
16.42 MAUD+30.19%
12.61 MAUD+46.54%
8.60 MAUD-38.48%
13.99 MAUD+5.05%
13.31 MAUD+56.74%
8.49 MAUD-6.77%
9.11 MAUD+236.17%
2.71 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TrivarX Stock analysis

What does TrivarX do? TrivarX Ltd generates revenue through its corporate health product, which provides mental well-being solutions for businesses. The company develops and commercializes mental health technology using objective biomarkers for screening, diagnosing, monitoring, and managing depression. Its consumer mobile application LUCA offers biometric assessments measuring sleep stress, activity stress, and cardiac stress, enabling users to monitor stress levels via personal wearable devices. The company focuses on early detection and screening of mental health conditions through clinical research and product development. The primary buyers of TrivarX's corporate health product are businesses seeking mental well-being solutions for their employees. The consumer application LUCA targets individuals interested in monitoring their stress levels using wearable technology. TrivarX's technology is designed to assist in the early detection and screening of mental health conditions, with a focus on depression management through objective biomarker analysis. The company's clinical research and product development activities support both business and consumer segments in the mental health technology market. TrivarX is one of the most popular companies on Eulerpool.

Equity Details

Analyzing TrivarX's Equity

TrivarX's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding TrivarX's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating TrivarX's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

TrivarX's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in TrivarX’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about TrivarX stock

The Equity of TrivarX is 15.97 M AUD in 2026.

The Equity of TrivarX changed from 12.65 M AUD to 15.97 M AUD, representing a 26.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity TrivarX since 2006 – with annual values, charts, and detailed analysis.

The Equity's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's TrivarX historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — TrivarX

All Key Metrics — TrivarX